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Abstract
Hypereosinophilic syndrome (HES) is defi ned by elevation more 
than 1.5×109/L of presence of a peripheral blood count, evidence of 
organ involvement, and exclusion of secondary eosinophilia such 
as allergic, vasculitis, drugs, or parasite infection and also clonal 
eosinophilia. We present the HES case with hepatic involvement. 
The patient is 70-year-old male. He complained fever and back 
pain. Blood examination showed marked peripheral eosinophilia, 
elevation of transaminase and biliary enzymes. Multiple irregular 
mass lesions of the liver were pointed out by CT and MRI. The 
liver biopsy was done for differentiation from malignancy. In pa-
renchyma, hepatic necrotic lesion was observed accompanying se-
vere eosinophilic infi ltration with Charcot-Leyden’s crystals. There 
was granulomatous reaction. He was diagnosed as HES and got 
recovery due to steroid therapy. From the review of HES article, the 
hepatic histology is categorized into four types as below: 1) cholan-
gitis type; 2) chronic active hepatitis type; 3) vasculopathic type, 4) 
hepatic necrosis type. Our case is classifi ed in hepatic necrosis type. 
This type seems to be important to distinguish malignant tumor and 
also visceral larva migrans by liver biopsy.
Keywords:  Charcot-Leyden’s crystal; Chronic eosinophilic leuke-
mia; Eosinophilia; Liver mass; Visceral larva migrans
Introduction
Prominent eosinophilic infi ltration of the liver is commonly 
seen in visceral larva migrans histologically presenting pali-
sading granuloma [1, 2]. Occasional eosinophilic infi ltration 
to some degree is known in drug-induced hypersensitivity 
as well as primary sclerosing cholangitis (PSC) [3], primary 
biliary cirrhosis (PBC) [4]. Hypereosinophilic syndrome 
(HES) is indispensable disease related to eosinophilic he-
patic necrosis, although it is rare.
Hypereosinophilic syndrome is thought to be a het-
erogeneous group of disorders characterized by peripheral 
eosinophilia and involvement of various organs. The diag-
nosis needs exclusion of other specifi c causes for eosino-
philia such as infectious disease (parasitosis), autoimmune 
diseases (Churg-Strauss syndrome, Wegener granulomato-
sis), allergic infl ammation to specifi c antigen, and neoplastic 
hematopoietic disorders [5]. Hepatic involvement of hypere-
osinophilic syndrome is uncommon, however, has been sug-
gested to associate with the various type of liver injury. For 
example, cholangitis [6], chronic active hepatitis (CAH) [7], 
Budd-Chiari syndrome [8], and nodular regenerative hyper-
plasia (NRH) [9] has been reported in the patients of hypere-
osinophilic syndrome. 
Herein, we present the case of hypereosinophilia with 
hepatic eosinophilic necrosis in liver histology and multiple 
liver mass lesions on radiological fi ndings, which was dif-
fi cult to differentiate from malignancy.
Case Report
  
A 70-year-old Japanese male complained fever and back 
pain. He was pointed out liver injury on blood examination. 
Imaging studies revealed multiple space-occupying lesion 
(SOL) of the liver. He was admitted for the examination 
of liver SOL. He has no familial history, no medication, no 
any allergy, animal pet, and habits of eating raw meat. In 
past history, he suffered cholecystlithiasis several years ago. 
Laboratory data at admission is shown in Table 1. The counts 
of white blood cell (WBC) elevated, particularly eosinophil 
increased markedly up to 62% (13200/μl). IgE RIST was 
high level and eosinophil cationic protein (ECP) was mildly 
elevated, which implied allergic or other infl ammatory 
reaction with involvement of the eosiophil in the process 
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[10]. The serologic test for Toxocara species was negative. 
Transaminase and biliary enzyme were moderately increased. 
Noticeable elevation of tumor markers was nothing, except 
for soluble interluekin-2 receptor (sIL-2R).
Radiological fi nding showed multiple mass lesions of 
the liver (Fig. 1). Those lesions were low density on ab-
dominal CT, which were not enhanced. MRI image showed 
low-intensity on T1-weight and iso-intensity on T2-weight. 
Metastatic tumor, cholangiocarcinoma, malignant lympho-
ma, and infl ammatory pseudotumor were candidates as dif-
Item Value Item Value
RBC 452 × 104 /μl (390 - 520 × 104 /μl) LDH 654 IU/l (110 - 220 IU/l)
WBC 213 × 102 /μl (33 - 90 × 102 /μl) CRP 2.7 mg/dl (< 0.3 mg/dl)
Eosinophil 62% (1-5%) IgE RIST 1457.2 IU/ml (< 400 IU/ml)
Platelet 17.3 × 104 /μl (15 - 35 × 104 /μl) ECP 33.0 μg/l (< 14.7 μg/l)
AST 110 IU/l (12 - 36 IU/l) IL-4 (-) (< 15 pg/ml)
ALT 108 IU/l (3 - 32 IU/l) IL-5 (-) (< 8 pg/ml)
ALP 499 IU/l (114 - 394 IU/l) IL-6 (-) (< 8 pg/ml)
γ-GTP 64 IU/l (9 - 71 IU/l) sIL-2R 4483 U/ml (190 - 650 U/ml)
Total 
bilirubin 0.57 mg/dl (0.1 - 1.0 mg/dl) DUPAN-2 273 U/ml (< 150 U/ml)
Total protein 6.1 g/dl (6.5 - 8.0 g/dl) 14 mAU/ml (< 40 mAU/ml)
Amylase 116 IU/l (58 - 166 IU/l) CA19-9 (-) (< 37 U/ml)
Creatinine 0.75 mg/dl (0.6 - 1.2 mg/dl) HBsAg (-)
BUN 13.7 mg/dl (10 - 20 mg/dl) HCV-Ab (-)
Table 1. Laboratory Data at Admission (Normal Range)
ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; BUN, blood 
urea nitrogen; CA19-9, Carbohydrate antigen 19-9; CRP, C-reactive protein; ECP, Eosinophil cationic pro-
tein; γ-GTP, gamma-glutamyl transpeptidase; HBsAg; hepatitis B surface antibody, HCV-Ab; hepatitis C 
virus antibody, IgE, immunoglobulin E; IL-4, interleukin-4; IL-5, interleukin-5; IL-6, interleukin-6; LDH, lactate 
dehydrogenase; PIVKA-II, protein induced by vitamin K absence or antagonist-II; Plt, platelet; RBC, red 
blood cell; sIL-2R, soluble interleukin-2 receptor; WBC, white blood cell.
Figure 1. Radiological fi ndings of the liver. (a) Enhanced CT of delayed phase. Multiple low density areas are detected in the 
whole liver. The lesions show nodular or geographic, and no enhanced effects. (b, c) MRI images. These lesions are iso or low 
intensity in T1-weight image (b), and iso or hyper intensity in T2-weight image (c).
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ferential diagnosis. Bilateral pleural effusion was pointed out 
in extrahepatic organ. 
After admission, he complained asthma-like symptom 
and pleural fl uid was detected by chest CT. The liver biop-
sy was performed for diagnosis of the mass lesions. Liver 
needle biopsy revealed multifocal eosinophile’s infi ltrative 
lesion in portal tracts and hepatic parenchyma (Fig. 2a, b). 
Cellular atypia of eosinophile was not distinct. The majority 
of infi ltrative cells were eosinophil in parenchyma, whereas 
lymphocytes were mixed to some degree in portal tracts. The 
lymphocytes showed small round nuclei without atypia, and 
polyclonal on immunohistological fi ndings. The granuloma-
tous reaction was not observed at all. The fragments of ne-
crotic tissue were seen here and there, and a lot of Charcot-
Leyden’s crystals were found in the necrotic area (Fig. 2c, d). 
The steroid pulse therapy was undergone after liver bi-
opsy. The count of eosinophile in peripheral blood fell down 
rapidly within normal range after steroid therapy. The he-
patic masses became gradually reduced and disappeared in 




Eosinophilia is generally categorized into clonal, secondary, 
and idiopathic types. Clonal eosinophilia is diagnosed by the 
presence of histologic, cytogenetic, or molecular evidence of 
an underlining myeloid malignancy. Actually, a lot of exami-
nation including the assessment of peripheral blood smear, 
bone marrow morphologic features, cytogenetic analysis, 
mutation analysis of specifi c gene, lymphocyte phenotyping, 
and T-cell receptor gene rearrangement are needed to rule 
out the clonal eosinophilia [11]. Our case is unlikely clonal 
type because of rapid improvement against steroid therapy, 
before vigorous examination.
Secondary eosinophilia is caused by parasite infection, 
allergic, systemic vasculitis, drugs, and nonmyeloid malig-
nancy. In our case, parasite infection, particularly visceral 
larva migrans, had to be differentiated because hepatic in-
volvement with eosinophilia and multiple lesion on imaging 
is frequently observed. To our knowledge, the characteris-
tic histological fi nding of parasitic infection is eosinophilic 
granuloma in almost cases, except one case of hydatid dis-
ease showing eosinophilic cholangitis [1, 2, 12-14]. It seemed 
that the possibility of visceral larva migrans could be denied 
because the granulomatous reaction was not found at all in 
liver biopsy, and antihelminthic treatment was not needed in 
our patient. Specifi c factor determining cause of eosinophilia 
didn’t detected over fi ve years, although it seems to be dif-
fi cult complete exclusion of secondary eosinophilia.
HES is a subcategory of idiopathic type, and defi ned by 
the presence of a peripheral blood eosinophil count of 1.5 × 
109/L or greater for at least 6 months, exclusion of both clon-
al and secondary eosinophilia, evidence of organ involve-
ment, like as Chusid et al. proposed in 1975 [11, 15]. This 
Figure 2. Histological fi ndings of the liver needle biopsy. (a) The foci of eosinophil’s aggregates and hepatocyte’s dropouts are 
seen in liver parenchyma (surrounded by head of arrow). (HE, original magnifi cation, x100). (b) The border of the eosinophile’s 
aggregates are relatively clear and cellular atypia of eosinophile are not apparent. (HE, original magnifi cation, x400). (c) Asterisk 
areas are composed necrotic cells (HE, original magnifi cation, x100). (d) (d) is high magnifi cation of the asterisk area of (c). 
Charcot-Leyden crystals are scattered in necrotic area, which show lightly eosinophilic and bipyramidal or hexagonal in shape on 
sections. (HE, original magnifi cation, x1000).
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Scheurlen et al 
[17]
2 41 M Abdominal pain, fever, jaundice






Grauer et al 
[6]
3 58 M Jaundice, fatigue, abdominal pain Normal Eosinophilic cholangitis Steroid
Dillon et al 
[18]


















Sussman et al 
[20]
6 20 M Fatigue, myalgia, night sweat NS
Chronic active hepatitis 
with eosinophilic 
infi ltration
Steroid AMA (NS)ANA (+)
Croffy et al 
[21]
7 34 M Nausea, jaundice NS
Chronic active hepatitis 
with eosinophilic 
infi ltration
Steroid AMA (NS)ANA (-)
Croffy et al 
[21]
8 19 M Jaundice, pruritic rash Hepatomegaly
Chronic active hepatitis 
with eosinophilic 
infi ltration
Steroid AMA (-)ANA (-)
Foong et al 
[7]
9 65 F Arthralgias Normal 
Chronic hepatitis with 
confl uent eosinophilic 
centrilobular necrosis











Bennie et al 
[9]
11 27 M Abdominal fullness
Obstruction of the 
hepatic veins and 












Inoue et al [8]
12 52 F Abdominal pain Liver masses Hepatic eosinophilic infi ltration Steroid Lai et al [23]
13 70 M Back pain, fever Liver masses Hepatic eosinophilic infi ltration Steroid Our case
Table 2. Reviewer of the Cases Reported as HES
AMA, anti-mitochondrial antibody; ANA, anti-nuclear antibody; F, female; FIP1L1, FIP1-like 1 gene; M, male; NRH, nodular regenerative hyper-
plasia; NS, not stated; PDGFRA, platelet derived growth factor receptor α; PSC, primary sclerosing cholangitis; UC, ulcerative colitis.
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case didn’t fi ll strictly above criteria, however, he was good 
responder of corticosteroid therapy, which is the fi rst-line 
therapy for HES [5]. A shorter duration by the proper therapy 
has been allowed for diagnosis for HES [11], therefore, this 
case likely to be HES. 
Liver involvement of the HES does occur in the frequen-
cy of 43% [16]. We review the cases reported as HES, which 
hepatic histology has been evaluated by liver biopsy in Table 
2. The variety of histological fi ndings seems refl ect the het-
erogeneity of HES. The hepatic histology of HES is classifi ed 
into four types: 1) cholangitis type; 2) chronic active hepa-
titis (CAH) type; 3) vasculopathic type; 4) hepatic necrosis 
type. Prominent eosinophilic infi ltration to portal tracts, bile 
ducts, venous system, or hepatic parenchyma were observed 
in each type. The characteristics and differential diagnosis 
are raised in each group. 1), Cholangitis type (case No. 1 
- 5). All patients were man and icteric. The discrimination 
form PSC were discussed quite often, because similarity of 
radiological or histological fi ndings, and also complication 
of eosinophilic colitis, which is consistent with infl ammatory 
bowel disease. 2), CAH type (case No. 6 - 9). Non-specifi c 
radiological fi nding, portal fi brosis with interface eosino-
philic hepatitis in histology, and practicable disease control 
by steroid therapy are characteristics in this groups. PBC, as 
well as autoimmune hepatitis (AIH) should be excluded by 
careful clinical follow up and repeated histological examina-
tion, because actually AMA-positive, or ANA-positive pa-
tient was reported [21, 22]. 3), Vasculopathic type (case No. 
10, 11). Case 11 with Budd-Chiari syndrome and FIP1L1-
PDGFRA fusion gene is currently categorized into myeloid 
and lymphoid neoplasm with eosinophilia and abnormali-
ties of platelet derived growth factor receptor α (PDGFRA), 
PDGFRB or fi ibroblast growth factor receptor (FGFR1) in 
the revised 2008 WHO classifi cation system, and defi nitely 
excluded from HES [24]. No abnormalities were detected in 
chromosomal analysis including Philadelphia chomosome in 
NRH patients (case No. 10) at the point, but the patients had 
persisted liver injury over two years despite of steroid, and 
also hydroxyurea, and thioguanine [9]. Vigorous examina-
tion of specifi c fusion gene and chromosomal abnormalities 
might be needed whenever encounter the vasculopathic type 
considering the possibility of neoplastic disease. 4), Hepatic 
necrosis type (case No. 12, 13). The notable characteristics 
of this group is hepatic multiple mass lesion pointed out on 
radiologists, which are diffi cult to distinguish from malig-
nancy, such as cholangiocellular carcinoma, metastatic car-
cinoma, or malignant lymphoma [25-27]. Needle biopsy 
seems essential to exclude above malignancy and also vis-
ceral larva migrans, which leads to avoid inappropriate sur-
gery or medication. The patients, just two in reports, both 
immediately improved against steroid therapy in clinical and 
radiological fi ndings, which seems to suggest that the group 
has unlikely neoplastic nature. Drug intake should always 
remind whenever eosinophilic infi ltration is seen in liver, if 
any pattern. 
We presented in this article the case of hepatic eosino-
philic necrosis showed liver mass lesions and reviewed the 
liver histology of HES. In conclusion, the histology is catego-
rized four types: cholangitis type, CAH type, vasculopathic 
type, and hepatic necrosis type. PSC, PBC, AIH, neoplastic 
eosinophilia, parasitic infection, malignancy, and drug can 
be differential disease in each type. It is important that HES 
is one of the mass forming disease in liver, and liver biopsy 
is useful to exclude differential disease for steroid therapy.
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